D. Schendel

发表

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

E. Meinl, M. Hummel, G. Schmitz, 1997, The Journal of clinical investigation.

Early transmembrane potential changes of lymphocytes in mixed lymphocyte cultures as detected by flow-cytometry

R. Wank, D. Schendel, C. Nerl, 1982, Naturwissenschaften.

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.

G. Riethmüller, B. Gansbacher, D. Schendel, 1993, Journal of immunology.

Autologous and Allogeneic Tumor Cell Vaccines

D. Schendel, E. Nössner, 1999 .

Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3

R. Wank, D. Schendel, T. Meo, 1982, The Journal of experimental medicine.

Isolation and characterization of a genomic HLA-Cw6 clone.

D. Schendel, A. Steinle, E. Nössner, 1992, Tissue antigens.

Clonal expression of differentiation and Ia‐like antigens on alloreactive human T lymphocytes

J. Johnson, R. Wank, D. Schendel, 1984, European journal of immunology.

CML: A Method for Cellular Typing

R. Wank, D. Schendel, W. Jennert, 1984 .

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

B. Gansbacher, D. Schendel, D. Schendel, 1993, Cancer research.

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

G. Willimsky, T. Blankenstein, D. Schendel, 2000, Gene Therapy.

Standardization of the human in vitro cell-mediated lympholysis technique.

B. Dupont, R. Wank, D. Schendel, 2008, Tissue antigens.

Genomic cloning and expression of HLA-B37 in the mouse mastocytoma cell line P815-HTR.

P. Nelson, D. Schendel, E. Nössner, 1991, Tissue antigens.

Cultured human T lymphocyte lines and clones as immunogenetic tools.

R. Wank, D. Schendel, 1984, Advances in experimental medicine and biology.

Noncodominant expression of target antigens recognized by human cytotoxic T lymphocytes.

R. Wank, D. Schendel, 1980, Human immunology.

Isolation of HLA-haplotype-specific human T-lymphocyte clones.

R. Wank, D. Schendel, 1981, Immunobiology.

Genetic Specificity of Primary and Secondary Proliferative and Cytotoxic Responses of Human Lymphocytes Grown in Continued Culture

R. Wank, D. Schendel, G. Bonnard, 1980, Scandinavian journal of immunology.

Postersession II: Nephrologie 2

C. Wanner, E. Ritz, G. Riethmüller, 1984 .

Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity

R. Tampé, S. Urlinger, B. Gansbacher, 2000, Gene Therapy.

Possible association between HLA‐DR5 and superficial spreading melanoma (SSM)

G. Riethmüller, D. Schendel, G. Mueller‐Eckhardt, 1984, International journal of cancer.

Two different HLA restimulating determinants separated by recombination and titration.

J. Hansen, B. Dupont, R. Wank, 1977, Transplantation proceedings.

Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.

J. Hansen, B. Dupont, R. Wank, 1977, Transplantation proceedings.

Secondary MLC Responses of Primed Lymphocytes after Selective Sensitization to Non‐HLA‐D Determinants

B. Dupont, R. Wank, D. Schendel, 1979, Scandinavian journal of immunology.

RARE VARIANT OF COMPLEMENT C4 IS SEEN IN HIGH FREQUENCY IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS

R. Wank, D. Schendel, G. O'Neill, 1984, The Lancet.

Cell-growth kinetics and karyotype analysis of human memory lymphocytes responding to alloantigen and mitogen.

R. Wank, D. Schendel, K. Miller, 1981, Immunobiology.

MLC workshop summary report.

D. Schendel, M. Segall, K. Zier, 2008, Tissue antigens.

Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy

G. Riethmüller, C. Falk, D. Schendel, 1997, Journal of Molecular Medicine.

HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

D. Schendel, A. Steinle, Alexander Steinle, 1994, Tissue antigens.

Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.

P. Nelson, G. Bornkamm, C. Reinhardt, 1992, Journal of immunology.

Production of human T cell growth factor.

R. Wank, D. Schendel, 1981, Human immunology.

Allogeneic vaccination for renal cell carcinoma: development and monitoring

B. Dörken, G. Willimsky, T. Blankenstein, 2000, Bone Marrow Transplantation.